In a groundbreaking medical achievement, Gleneagles Hospital, Parel, successfully treated a 61-year-old man suffering from Achalasia, a rare swallowing disorder that affects the oesophagus. The patient, Suhas R. Mungaker, endured two years of severe swallowing difficulties before finding relief through a minimally invasive procedure led by Dr. Megraj Ingle, Director and Senior Consultant of Gastroenterology.
Mungaker’s condition began with frequent hiccups during meals, which he initially dismissed. Over time, he experienced a sensation of food getting stuck in his throat, forcing him to drink water to swallow. Despite brief periods of relief, his symptoms worsened, with heartburn and persistent discomfort following meals. A consultation with Dr. Ingle revealed the rare condition known as Achalasia, where the oesophagus struggles to move food and liquids into the stomach due to a failure of the lower oesophagal sphincter to relax.
Dr. Ingle explained, “The patient was experiencing severe difficulty in eating, chest pain, and significant weight loss. An endoscopy showed a narrowing of the esophagus near the stomach, with multiple blockages and a structure resembling a bird’s beak—a classic sign of Achalasia. The condition is rare, affecting only one in a million individuals. At our center, we encounter 10 to 20 cases annually.”
Further diagnostic tests, including a barium swallow, confirmed that the muscles of the oesophagus were enlarged and obstructing food passage. Dr. Ingle performed a minimally invasive endoscopic procedure, creating a tunnel between the layers of the oesophagal wall and cutting the lower oesophagal muscle to allow proper passage of food. The patient’s recovery was swift, and he was able to eat normally the day he was discharged.
“It was terrifying when my condition worsened, and I struggled to eat. I am incredibly grateful to Dr. Ingle and his team for their timely intervention. I can now enjoy my favourite meals without any trouble,” said Mungaker, expressing his gratitude.
Dr. Bipin Chevale, CEO of Gleneagles Hospital, emphasised the institution’s advanced capabilities in treating rare conditions. “Our state-of-the-art technology and diagnostic tools enable us to address even the most complex disorders with precision and care. This achievement highlights our commitment to delivering the most innovative and effective treatments for patients.”
The successful treatment of Mungaker showcases Gleneagles Hospital’s expertise in managing rare medical conditions, offering hope to others facing similar challenges.
